Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Gene therapy for muscular dystrophy stirs hopes and controversy

The FDA is considering greenlighting the experimental treatment under its accelerated approvals program. Some critics point out the therapy isn't yet proven to work and may be costly.

WEKU

Dermatologists Talk Daxxify, the Newest Player on the Neuromodulator Scene

Daxxify claims to last twice as long as its competitors—but is that true?

Marie Claire

DNA sequencing platform hit by serious security flaws

One of the two vulnerabilities discovered carries a 10/10 severity score.

TechRadar

From analysis to the latest developments in health,
read the most diverse news in one place.

Can drugs fix the UK’s adolescent obesity crisis?

A powerful new weight-loss medication may be approved for those aged 12 to 17. But healthcare professionals fear it ignores the underlying socioeconomic causes

The Guardian - UK

The Former Pro Athletes Turning to Magic Mushrooms for Relief

The use of psychedelic mushrooms is gaining traction in the United States. Many researchers predict FDA approval of a psychedelic treatment will come within the next five years.

Inverse

Explained | Can psychedelics treat depression? A doctor explains.

Can psychedelic drugs create lasting positive changes in brain function? The Hindu explains the potential benefits of their use in treating depression. Subscribe now to read the full article.

The Hindu

Hepatitis A outbreak worsens

You may want to skip the frozen fruits section at your grocery store until the recent recalls have been lifted

Salon

Read news from The Economist, FT, and more,
with one subscription

Cannabis-derived products like delta-8 THC and delta-10 THC have flooded the US market – two immunologists explain the medicinal benefits and potential risks

These days you see signs for delta-8 THC, delta-10 THC and CBD, or cannabidiol, everywhere – at gas stations, convenience stores, vape shops and online. Many people are rightly wondering which of these compounds are legal, whether it is safe to consume them and which of their supposed medicinal benefits…

The Conversation

FDA approves 1st pill made from human poop

The Food and Drug Administration approved the second-ever medical treatment made from donated human feces.

LiveScience

Vermont passes bills aimed at protecting abortion pills

The Vermont Legislature has passed reproductive and gender-affirming health care bills with a late addition aimed at protecting access to a medication widely used in abortions — even if the U.S. Food and Drug Administration withdraws its approval of mifepristone

The Independent UK

Social Media adds to weight loss craze

GLP-1 agonists are a class of weight loss drug that is going viral on social media — but misinformation is rife

Salon

Eli Lilly releases more data for new obesity drug, moving toward fast-track approval

There's already a huge demand for existing weight-loss drugs, so the new medication is highly anticipated. Obesity affects an estimated 650 million adults globally.

WEKU

FDA approves first-ever pill made from healthy gut bacteria found in human waste

The pill paves way for an easier way of performing so-called faecal transplants

The Independent UK

First pill for fecal transplant wins FDA approval

U.S. health officials have approved the first pill that uses healthy bacteria from human waste to fight dangerous gut infections — an easier way of performing so-called fecal transplants

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

LiveScience

Don't use 'amniotic fluid' eye drops, FDA warns

"Amniotic fluid" eye drops aren't approved and could be harmful, the Food and Drug Administration warned.

The Independent UK

Missouri judge to weigh transgender health care rules

A Missouri judge will decide whether a first-of-its-kind rule placing strict regulations on gender-affirming care in Missouri kicks in Thursday

The Conversation

Challenging the FDA's authority isn't new – the agency's history shows what's at stake when drug regulation is in limbo

Political pressure is nothing new for the U.S. Food and Drug Administration. The agency has frequently come under fire for its drug approval decisions, but attacks on its decision-making process and science itself have increased during the COVID-19 pandemic.

The Conversation

Mifepristone is under scrutiny in the courts, but it has been used safely and effectively around the world for decades

A flurry of court rulings in April 2023 has left the future of the abortion pill mifepristone in question. For now, a U.S. Supreme Court decision on April 21 allows the drug to remain accessible without additional restrictions as the merits of the case are weighed in lower court proceedings.

Get all your
news in one place.

100's of premium titles.
One news app.

LiveScience

Most melatonin gummies have higher doses than what's on the label

A new analysis reveals that most melatonin gummies sold in the U.S. contain more of the hormone than noted on their labels.

The Independent UK

Father reveals reason why he shared hospital photo of son who died in ‘TikTok Benadryl challenge’

Jacob Stevens, 13, died six days after attempting the deadly challenge

The Independent UK

Drug for rare form of Lou Gehrig’s disease OK'd by FDA

U.S. health regulators have approved a first-of-a-kind drug for a rare form of Lou Gehrig’s disease

Fortune

The human genome revealed its secrets 20 years ago. It’s time to fulfill its promise of personalized health care

Genetics have the potential to transform how we predict, prevent, and treat almost all human disease, writes 23andMe CEO Anne Wojcicki.

Axios

Your dog can join you for outdoor dining, FDA says

It's safe from a health perspective for dogs to sit on a café's patio, the FDA says.

The Independent UK

ACLU sues to block Missouri rule on transgender health care

The ACLU is suing to block new Missouri restrictions on both adults and children seeking gender-affirming health care

Kiplinger

This Company Is Solving A $1B Problem, And It’s Creating An Opportunity For Investors

One of the largest burdens faced by people over 50 is spinal discomfort. Dymicron invented an option poised to help patients in need of a breakthrough – representing a $1B potential addressable market. For a limited time, the company is taking investors to help share their innovation with the world.

1 … 147 148 149 150

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

347 stories

KFF Health News

231 stories

the Food and Drug Administration

214 stories

Biogen

208 stories

The National Institutes of Health

157 stories

23andMe

147 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.